MedTrace Logo

Effect of Supragingival Control Versus Supra- and Subgingival Control in the Periodontal Health During the Maintenance

NCT01598155 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2014-12-09

No results posted yet for this study

Summary

Seventy patients will be previously treated for moderate-to-severe periodontitis according to their individual needs. Thirty days after completion of periodontal treatment, these patients will be randomized to one of the following groups of periodic preventive maintenance (PPM): G1 - performed only control supragingival; G2 - performed supra and subgingival control (when necessary).

The maintenance consultations will be scheduled every 3 months for 24 months. The hypothesis is that the effect of the supragingival control (conducted over 24 months) will be similar to the effect of the supra- and subgingival control combined, above the restoration and progression of periodontitis.

Conditions

  • Periodontitis

Interventions

PROCEDURE

Group 1 - Supragingival biofilm control

30 days after the end of periodontal treatment, participants assigned to this group, will receive every 3 months (over 24 months): * Scaling, planning and polishing coronary surface; * Education and motivation for oral hygiene and daily supragingival biofilm control by the patient.

PROCEDURE

Group 2 - Supra- and subgingival biofilm control

30 days after the end of periodontal treatment, participants assigned to this group, will receive every 3 months (over 24 months): * Scaling, planning and polishing of coronary surface; * Education and motivation for oral hygiene and daily supragingival biofilm control by the patient; * Subgingival scaling and root planning in sites with persistent bleeding on probing and probing depth unchanged.

Sponsors & Collaborators

  • Federal University of Rio Grande do Sul

    lead OTHER

Principal Investigators

  • Sabrina Carvalho Gomes, DDS, PhD · Federal University of Rio Grande do Sul

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01598155 on ClinicalTrials.gov